Development of diabetes after gatifloxacin therapy

Am J Health Syst Pharm. 2005 Nov 1;62(21):2293-5. doi: 10.2146/ajhp050119.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Blood Glucose
  • Cellulitis / drug therapy
  • Diabetes Mellitus, Type 2 / chemically induced*
  • Fluoroquinolones / adverse effects*
  • Fluoroquinolones / therapeutic use
  • Gatifloxacin
  • Humans
  • Leg Ulcer / drug therapy
  • Male
  • Middle Aged

Substances

  • Anti-Bacterial Agents
  • Blood Glucose
  • Fluoroquinolones
  • Gatifloxacin